The anti-herpes simplex virus activity of n-docosanol includes inhibition of the viral entry process-Reference-Cited by-同舟云学术

The anti-herpes simplex virus activity of n-docosanol includes inhibition of the viral entry process

Published:1998-12 Issue:1-2 Volume:40 Page:85-94
ISSN:0166-3542
Container-title:Antiviral Research
language:en
Short-container-title:Antiviral Research

Author:

Pope Laura E,Marcelletti John F,Katz Lee R,Lin Janet Y,Katz David H,Parish Mary Lynn,Spear Patricia G

Publisher

Elsevier BV

Subject

Virology,Pharmacology

Reference21 articles.

1. Dynamics of membrane lipid metabolism and turnover;Dawidowicz;Annu. Rev. Biochem.,1987

2. Specificities of monoclonal antibodies that inhibit adsorption of herpes simplex virus to cells and lack of inhibition by potent neutralizing antibodies;Fuller;J. Virol.,1985

3. Anti-glycoprotein D antibodies that permit adsorption but block infection by herpes simplex virus 1 prevent virion-cell fusion at the cell surface;Fuller;Proc. Natl. Acad. Sci. USA,1987

4. Entry of alphaherpesviruses mediated by poliovirus receptor-related protein 1 and poliovirus receptor;Geraghty;Science,1998

5. n-Docosanol 10% cream in the treatment of recurrent herpes labialis: A randomised, double-blind, placebo-controlled study;Habbema;Acta Derm.-Venereol. (Stockh.),1996

Cited by 77 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Chemical Composition, Antifungal, Antibacterial, Antioxidant, Antiviral and Cytotoxic Activities of Ruta chalepensis L. Fixed Oil from Saudi Arabia;Journal of Biobased Materials and Bioenergy;2024-07-01

2. Novel inhibitors of HSV-1 protease effective in vitro and in vivo;Antiviral Research;2023-05

3. Antiviral Mechanism of Virucidal Sialic Acid Modified Cyclodextrin;Pharmaceutics;2023-02-09

4. An Insight into Current Treatment Strategies, Their Limitations, and Ongoing Developments in Vaccine Technologies against Herpes Simplex Infections;Vaccines;2023-01-17

5. Acyclovir resistance in herpes simplex viruses: Prevalence and therapeutic alternatives;Biochemical Pharmacology;2022-12